Paragon Financial Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,210
Closed -$408K 82
2023
Q3
$408K Hold
5,210
0.42% 43
2023
Q2
$459K Hold
5,210
0.43% 43
2023
Q1
$420K Buy
5,210
+180
+4% +$14.7K 0.44% 45
2022
Q4
$391K Hold
5,030
0.43% 46
2022
Q3
$406K Hold
5,030
0.46% 37
2022
Q2
$451K Hold
5,030
0.46% 41
2022
Q1
$558K Hold
5,030
0.49% 38
2021
Q4
$520K Buy
+5,030
New +$582K 0.43% 48

Other funds holding MDT

Paragon Financial Partners's MDT Position: Q4 2023 in Review

Paragon Financial Partners sold out of Medtronic (MDT) in Q4 2023, closing a stake of 5,210 shares — an estimated $408K sold.

Paragon Financial Partners first reported a position in MDT in Q4 2021 and held it in 8 quarters. The position peaked at $558K in Q1 2022. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • Paragon Financial Partners reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • Paragon Financial Partners sold 5,210 Medtronic shares in Q4 2023, an estimated $408K.
  • Paragon Financial Partners first reported a position in Medtronic in Q4 2021 and held it in 8 quarters.
  • Paragon Financial Partners's Medtronic position peaked at $558K in Q1 2022.
  • 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Paragon Financial Partners's 13F filing for Q4 2023, filed 29 Jan 2024.